Moderna entered the S&P 500 on July 21, 2021
Moderna entered the S&P 500 on July 21, 2021

Moderna replaced Alexion Pharmaceuticals Inc. in the S&P 500 effective prior to the opening of trading on Wed., July 21, according to a statement.